Vaccines: Boosting Confidence

Co-Moderator(s)

• 

  Priscilla Velentgas, MS, PhD (she/her/hers)

  Senior Principal Scientist
  Merck
• 

  Kathleen Andersen, PhD (she/her/hers)

  Director, Vaccines Real World Evidence
  Pfizer
  New York, United States

Presentations:

• 1:00 PM – 1:15 PM ADT

  Effectiveness of BNT162b2 COVID-19 Vaccine in US Children Aged 5-17 Years
  

  Presenting Author: Rachel Ogilvie, PhD, MPH – Optum Epidemiology
• 1:15 PM – 1:30 PM ADT

  Short-Term Effectiveness of Bivalent COVID-19 mRNA Booster Vaccinations in the Veterans Health Administration Using Self-Controlled Risk Interval and Test-Negative Case-Control Designs
  

  Presenting Author: Caroline Korves, ScD (she/her/hers) – White River Junction Veterans Affairs Medical Center, White River Junction, VT
• 1:30 PM – 1:45 PM ADT

  COVID-19 vaccine effectiveness against Post COVID-19 condition – A register-based cohort study among 589,722 individuals in Sweden
  

  Presenting Author: Lisa Lundberg – Department of Microbiology and Immunology, Institute of Biomedicine, the Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden
• 1:45 PM – 2:00 PM ADT

  Risk of Breakthrough SARS-CoV-2 Infection and Clinical Outcomes Among Patients with Type 2 Diabetes
  

  Presenting Author: Sungho Bea, PharmD – School of Pharmacy, Sungkyunkwan University, Suwon, South Korea
• 2:00 PM – 2:15 PM ADT

  Associations between HLA variations and serological response to COVID-19 vaccination: an analysis of UK Biobank antibody survey data
  

  Presenting Author: Junqing Xie, MBBS, MSc, DPhil – Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford
• 2:15 PM – 2:30 PM ADT

  The impact of HLA-DQB1*06 alleles on COVID-19 vaccine effectiveness: an analysis of SARS-CoV-2 antibodies and breakthrough infections based on UK Biobank
  

  Presenting Author: Junqing Xie, MBBS, MSc, DPhil – Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford